(Q33583284)

28 July 2017

1 reference

title

Use of quality-of-life outcome assessments in current cancer clinical trials (English)

1 reference

28 July 2017

1 reference

C C Gotay

1

1 reference

28 July 2017

M Wilson

series ordinal

2

1 reference

28 July 2017

publication date

1 June 1998

1 reference

Evaluation and the Health Professions

28 July 2017

published in

1 reference

28 July 2017

volume

21

1 reference

28 July 2017

issue

2

1 reference

28 July 2017

page(s)

157-178

1 reference

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F016327879802100203

Psychosocial outcomes of cancer: a comparative analysis of Hodgkin's disease and testicular cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F016327879802100203

Measurement of quality of life in localized prostatic cancer patients treated with radiotherapy. Development of a prostate cancer-specific module supplementing the EORTC QLQ-C30.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F016327879802100203

The Head and Neck Radiotherapy Questionnaire: a morbidity/quality-of-life instrument for clinical trials of radiation therapy in locally advanced head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F016327879802100203

Quality of life in cancer: definition, purpose, and method of measurement

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F016327879802100203

The Functional Assessment of Cancer Therapy scale: development and validation of the general measure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F016327879802100203

Prevalence of menopausal symptoms among women with a history of breast cancer and attitudes toward estrogen replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F016327879802100203

Quality of life after breast cancer surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F016327879802100203

Should the elderly receive chemotherapy for node-negative breast cancer? A cost-effectiveness analysis examining total and active life-expectancy outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F016327879802100203

Relation between tumor size, quality of life, and survival in patients with colorectal liver metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F016327879802100203

A comprehensive multiattribute system for classifying the health status of survivors of childhood cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F016327879802100203

Placebo-blinded study of morphine sulfate sustained-release tablets and immediate-release morphine sulfate solution in outpatients with chronic pain due to advanced cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F016327879802100203

Quality-of-life assessment in cancer treatment protocols: research issues in protocol development

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F016327879802100203

Educational, occupational, and insurance status of childhood cancer survivors in their fourth and fifth decades of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F016327879802100203

Trade-offs between survival and breast preservation for three initial treatments of ductal carcinoma-in-situ of the breast.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F016327879802100203

Late psychosocial sequelae in Hodgkin's disease survivors: a French population-based case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F016327879802100203

Effect of schedule and maintenance on the antiemetic efficacy of ondansetron combined with dexamethasone in acute and delayed nausea and emesis in patients receiving moderately emetogenic chemotherapy: a phase III trial by the National Cancer Instit

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F016327879802100203

Effect of megestrol acetate on quality of life in a dose-response trial in women with advanced breast cancer. The Cancer and Leukemia Group B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F016327879802100203

Cisplatin, vinblastine, and hydrazine sulfate in advanced, non-small-cell lung cancer: a randomized placebo-controlled, double-blind phase III study of the Cancer and Leukemia Group B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F016327879802100203

Placebo-controlled trial of hydrazine sulfate in patients with newly diagnosed non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F016327879802100203

Randomized placebo-controlled evaluation of hydrazine sulfate in patients with advanced colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F016327879802100203

Randomized trial of a psychologic distress screening program after breast cancer: effects on quality of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F016327879802100203

Quality of life end points in cancer clinical trials: review and recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F016327879802100203

The development and psychometric validation of a brain cancer quality-of-life questionnaire for use in combination with general cancer-specific questionnaires

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F016327879802100203

Effect of dietary counseling on food intake, body weight, response rate, survival, and quality of life in cancer patients undergoing chemotherapy: a prospective, randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F016327879802100203

Quality of life variables in surgical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F016327879802100203

Effects of mastectomy versus lumpectomy on emotional adjustment to breast cancer: a prospective study of the first year postsurgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F016327879802100203

Randomized double-blind placebo-controlled trial of cisplatin and etoposide plus megestrol acetate/placebo in extensive-stage small-cell lung cancer: a North Central Cancer Treatment Group study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F016327879802100203

Characteristics of women at risk for psychosocial distress in the year after breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F016327879802100203

Effects of medroxyprogesterone acetate on appetite, weight, and quality of life in advanced-stage non-hormone-sensitive cancer: a placebo-controlled multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F016327879802100203

The role of health care providers and significant others in evaluating the quality of life of patients with chronic disease: A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F016327879802100203

The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F016327879802100203

A modular questionnaire for the assessment of longterm quality of life in leukaemia patients: the MRC/EORTC QLQ-LEU.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F016327879802100203

10.1177/016327879802100203

21 January 2018

Identifiers

DOI

1 reference

28 July 2017

1 reference